NME3 promotes clear cell renal cell carcinoma progression and modulates TKI response through MFN1/2-dependent mitochondrial fusion and mitophagy suppression. - Cao S; Chen X; Zhang C; Feng Y; Shi C; Wang J; Xu Q; Huang X; Ma X; Fan W (Oncogene, 2026)